From Yahoo Finance: 2025-05-26 11:35:00

Jim Cramer expressed skepticism towards Moderna Inc. (MRNA) despite acknowledging potential value, citing a longstanding negative stance. The stock, a biotech company focusing on mRNA technology for vaccines and treatments, has seen a decline, possibly due to negative news. While MRNA ranks 3rd on Cramer’s list, AI stocks are seen as more promising.



Read more at Yahoo Finance: “I’ve Been Against This Stock For So Long”